Login
Toggle navigation
Videos
Categories
Trending
Tomas J. Svoboda, CEO, Elanix Biotechnologies
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Introduction to Elanix Biotechnologies by Tomas J. Svoboda, CEO
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Teemu Suna on Revolutionizing Global Healthcare with Nightingale Health | Teemu Suna, CEO , Nightingale Health Oyj.
00:10:00
Choosing a Certified Financial Planner®: Key Red Flags to Watch Out For |Lauren Zangardi Haynes, Founder, Spark Financial Advisors, LLC.
00:10:00
Presentation on Battery Minerals' Monte Perez Graphite Project in Mozambique.
00:10:00
Labrador Gold CEO Discusses Kingsway Sale and Future Exploration Plans
00:10:00
Navigating ESOP Transactions in Today's Market: Insights and Strategies
00:10:00
Alexandre Birman: Navigating Personal Loss and Business Growth Amidst Challenges | Alexandre Birman, CEO, Arezzo Industria e Comercio SA.
00:10:00
Ecorodovias | Guidelines for 2021 | Marcello Guidotti - CEO of ECORODOVIAS INFRAESTRUTURA E LOGISTICA S.A.
00:10:00
Catalyst Metals Targets 200K Oz Annual Gold Production with Strategic Acquisitions
00:10:00
Exploring the Future of Nuclear Power: Uranium Opportunities in Namibia and Australia
00:10:00
Holistic Wealth Management: Connecting Life Goals with Financial Success
00:10:00
Gold Expansion Prospects: Garden Rooms' Maiden Resource and Future Drilling Plans at One-to-One Conference in London
00:10:00
Exploring the Potential of Copper, Zinc, and Silver Deposits in Ireland: IMC Exploration Group's Progress and Plans | Eamon O’Brien, Chairman at IMC Exploration Group PLC